Prognostic and Predictive Biomarkers in the Era of Immunotherapy for Lung Cancer
The therapeutic algorithm of lung cancer has recently been revolutionized by the emergence of immune checkpoint inhibitors. However, an objective and durable response rate remains low with those recent therapies and some patients even experience severe adverse events. Prognostic and predictive bioma...
Main Authors: | Lucile Pabst, Sébastien Lopes, Basil Bertrand, Quentin Creusot, Maria Kotovskaya, Erwan Pencreach, Michèle Beau-Faller, Céline Mascaux |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/8/7577 |
Similar Items
-
RCC Real-World Data: Prognostic Factors and Risk Stratification in the Immunotherapy Era
by: Shira Sagie, et al.
Published: (2022-06-01) -
Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysis
by: Sébastien Lopes, et al.
Published: (2023-01-01) -
An update on methods for detection of prognostic and predictive biomarkers in melanoma
by: Oluwaseyi Adeuyan, et al.
Published: (2023-10-01) -
Molecular Mechanism of EGFR-TKI Resistance in <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer: Application to Biological Diagnostic and Monitoring
by: Damien Reita, et al.
Published: (2021-09-01) -
Direct Targeting <i>KRAS</i> Mutation in Non-Small Cell Lung Cancer: Focus on Resistance
by: Damien Reita, et al.
Published: (2022-03-01)